Deals

Regado Bioscience Raises $20M at 20% Discount via Cowen, BMO

By |

Regado Bioscience, Inc. (RGDO) announced that it has raised $20,000,000 in a Common Stock transaction. The common stock was sold at $5.00 per share, an approximate 20% discount to the market price ($6.25) of RGDO at deal announcement. Cowen and Company, LLC acted as the Lead Agent with BMO Capital Markets Corp. acting as Co-Agent on the transaction. Issuer counsel was Lowenstein Sandler, PC and Goodwin Procter was Placement Agent Counsel. Note this Placement is subject to customary closing conditions and is expected to close by 02/05/2014. via PlacementTracker.

Deals

Atossa Genetics Closes $14M CMPO via Dawson James

By |

Atossa Genetics Inc. (ATOS) announced that it has raised $13,920,000 in a CMPO/Overnight transaction. The common stock was sold at $2.40 per share, an approximate 25% discount to the market price ($3.20) of ATOS at deal announcement. A series of 1,160,000 60-Month Warrants with an exercise price of $3.00 per share (6.25% discount) was issued to the investors in this transaction. Dawson James Securities, Inc. acted as the Sole Book-Runner on the transaction. Underwriter counsel was Ellenoff Grossman & Schole LLP and issuer counsel was Ropes & Gray.

Deals

NanoViricides Raises $20M in RDO at 13% Discount via Chardan Capital, Midtown Partners

By |

NanoViricides, Inc. (NNVC) announced that it has raised $20,030,246 in a Registered Direct transaction. The common stock was sold at $5.25 per share, an approximate 13% discount to the market price ($6.05) of NNVC at deal announcement. A series of 2,479,935 60-Month Warrants with an exercise price of $6.05 per share was issued to the investors in this transaction. Chardan Capital Markets acted as Lead Agent with Midtown Partners as Co-Agent on the transaction. Placement Agent counsel was Gracin & Marlow and issuer counsel was Kane Kessler.